Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens

The standard of care for patients with acute promyelocytic leukaemia (APL) relapsing after front‐line treatment with arsenic trioxide (ATO)‐based regimens remains to be defined. A total of 67 patients who relapsed after receiving ATO‐based up‐front therapy and were also salvaged using an ATO‐based r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Haematol
Autors principals: Fouzia, N. A., Sharma, Vibhor, Ganesan, Saravanan, Palani, Hamenth K., Balasundaram, Nithya, David, Sachin, Kulkarni, Uday P., Korula, Anu, Devasia, Anup J., Nair, Sukesh C., Janet, Nancy Beryl, Abraham, Aby, Mani, Thenmozhi, Lakshmanan, Jeyaseelan, Balasubramanian, Poonkuzhali, George, Biju, Mathews, Vikram
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Haematological Malignancy ‐ Clinical
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894296/
https://ncbi.nlm.nih.gov/pubmed/33216980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars